Efficacy and safety of multitarget therapy with mizoribine and tacrolimus for systemic lupus erythematosus with or without active nephritis.

Nomura, A; Shimizu, H; Kishimoto, M; Suyama, Y; Rokutanda, R; Ohara, Y; Yamaguchi, K; Okada, M

Nomura, A; Shimizu, H; Kishimoto, M; Suyama, Y; Rokutanda, R; Ohara, Y; Yamaguchi, K; Okada, M.

Affiliation

Nomura A; Division of Allergy and Rheumatology, St Luke's International Hospital, Tokyo, Japan. nomura.a24@gmail.com

Lupus ; 21(13): 1444-9, 2012 Nov.

Article in En | MEDLINE | ID: mdl-22917589

Subject(s)

Immunosuppressive Agents/therapeutic use; Lupus Erythematosus, Systemic/drug therapy; Lupus Nephritis/drug therapy; Ribonucleosides/therapeutic use; Tacrolimus/therapeutic use; Adult; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents/administration & dosage; Immunosuppressive Agents/adverse effects; Lupus Erythematosus, Systemic/complications; Lupus Erythematosus, Systemic/diagnosis; Lupus Nephritis/diagnosis; Lupus Nephritis/etiology; Male; Middle Aged; Remission Induction; Retrospective Studies; Ribonucleosides/administration & dosage; Ribonucleosides/adverse effects; Tacrolimus/administration & dosage; Tacrolimus/adverse effects; Time Factors; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ribonucleosides / Lupus Nephritis / Tacrolimus / Immunosuppressive Agents / Lupus Erythematosus, Systemic Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Lupus Journal subject: REUMATOLOGIA Year: 2012 Type: Article Affiliation country: Japan

Fulltext

XML

PubMed Links

Search on Google